STOCK TITAN

Monthly information on share capital and company voting rights

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Cellectis (CLLS) reports a total number of shares in the capital and voting rights as of January 31, 2024. The company's ISIN code is FR0010425595 and is listed on Euronext Growth. Media and investor relations contacts are provided for further information.
Positive
  • None.
Negative
  • None.

(Article 223-16 of General Regulation of the French financial markets authority)

PARIS, Feb. 02, 2024 (GLOBE NEWSWIRE) --

Listing market: Euronext Growth

ISIN code: FR0010425595

DateTotal number of shares
in the capital
Total number of voting
rights
01/31/202471,751,20177,686,818

For further information on Cellectis, please contact:     

Media contact:       

Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, media@cellectis.com

Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93, media@cellectis.com

Investor Relations contacts:       

Arthur Stril, Chief Business Officer, +1 (347) 809 5980, investors@cellectis.com

Ashley R. Robinson, LifeSci Advisors, +1 617 430 7577  

Attachment


FAQ

What is the ISIN code for Cellectis?

The ISIN code for Cellectis is FR0010425595.

Where is Cellectis listed?

Cellectis is listed on Euronext Growth.

What are the total number of shares in the capital and voting rights reported by Cellectis?

As of January 31, 2024, Cellectis reported 71,751,201 shares in the capital and 77,686,818 voting rights.

Who are the media contacts for Cellectis?

The media contacts for Cellectis are Pascalyne Wilson and Patricia Sosa Navarro.

Who are the investor relations contacts for Cellectis?

The investor relations contacts for Cellectis are Arthur Stril and Ashley R. Robinson.

Cellectis S.A. American Depositary Shares

NASDAQ:CLLS

CLLS Rankings

CLLS Latest News

CLLS Stock Data

154.14M
93.36M
3.87%
16.65%
0.14%
Biotechnology
Healthcare
Link
United States of America
Paris